| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |